Prognostic value of international neuroblastoma pathology classification in localized resectable peripheral neuroblastic tumors: A histopathologic study of Localized Neuroblastoma European Study Group 94.01 trial and protocol

Journal of Clinical Oncology

Volumn 24, Issue 4, 2006, Pages 695-699

  Navarro, Samuel ^a   Amann, Gabriele ^b   Beiske, Klaus ^b   Cullinane, Catherine J ^b   D'Amore, Emanuele S G ^b   Gambini, Claudio ^b   Mosseri, Véronique ^b   De Bernardi, Bruno ^b   Michon, Jean ^b   Peuchmaur, Michel ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ARTICLE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR LOCALIZATION; BLOOD; CLASSIFICATION; CLINICAL TRIAL; DISEASE FREE SURVIVAL; ENZYMOLOGY; EUROPE; MULTICENTER STUDY; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL; TREATMENT OUTCOME;

DISEASE-FREE SURVIVAL; EUROPE; GANGLIONEUROBLASTOMA; HUMANS; L-LACTATE DEHYDROGENASE; NEUROBLASTOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33644838706     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.00.8631     Document Type: Article

References (20)

1. Berthold F, Brandeis W, Lampert F: Neuroblastoma: Diagnostic advances and therapeutic results in 370 patients. Monogr Paediatr 18:206-223, 1986
2. de Bernardi B, Rogers D, Carli M, et al: Localized neuroblastoma: Surgical and pathologic staging. Cancer 60:1066-1072, 1987
3. Castleberry RP, Kun LE, Shuster JJ, et al: Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol 9789-795 1991
4. Seeger R, Brodeur G, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. N Engl J Med 313:1111-1116, 1985
5. Rosen E, Cassady J, Kretschmar C, et al: Influence of local-regional lymph node metastases on prognosis in neuroblastoma. Med Pediatr Oncol 12:260-263, 1984
6. Perez CA, Matthay KK, Atkinson JB, et al: Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: A Children's Cancer Group study. J Clin Oncol 18:18-26, 2000
7. Shimada H, Ambros IM, Dehner LP, et al: Terminology and morphologic criteria of neuroblastic tumors: Recommendations by the International Neuroblastoma Pathology Committee. Cancer 86:349-363, 1999
8. Shimada H, Ambros IM, Dehner LP, et al: The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86: 364-372, 1999
9. Peuchmaur M, d'Amore E, Joshi V, et al: Revision of the International Neuroblastoma Pathology Classification: Confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma nodular. Cancer 98:2274-2281, 2003
10. Brodeur GM: Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 3:203-216, 2003
11. Beckwith JB, Martin RF: Observations on the histopathology of neuroblastomas. J Pediatr Surg 3:106-110, 1968
12. Joshi VV, Cantor AB, Altshuler G, et al: Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification: A clinicopathologic study of 213 cases from the Pediatric Oncology Group. Cancer 69:2183-2196, 1992
13. Joshi VV, Rao PV, Cantor AB, et al: Modified histologic grading of neuroblastomas by replacement of mitotic rate with mitosis karyorrhexis index: A clinicopathologic study of 223 cases from the Pediatric Oncology Group. Cancer 77:1582-1588, 1996
14. Shimada H, Chatten J, Newton WA, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
15. Umehara S, Nakagawa A, Matthay KK, et al: Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular. Cancer 89:1150-1161, 2000
16. Ikeda H, Iehara T, Tsuchida Y, et al: Experience with International Neuroblastoma Staging Systern and Pathology Classification. Br J Cancer 86: 1110-1116, 2002
17. Joshi VV, Cantor AB, Brodeur GM, et al: Correlation between morphologic and other prognostic markers of neuroblastoma: A study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group. Cancer 71:3173-3181, 1993
18. Joshi VV, Tsongalis GJ: Correlation between morphologic and nonmorphologic prognostic markers of neuroblastoma. Ann N Y Acad Sci 824:71-83, 1997
19. Shuster JJ, McWilliams NB, Castleberry R, et al: Serum lactate dehydrogenase in childhood neuroblastoma: A Pediatric Oncology Group recursive partitioning study. Am J Clin Oncol 15:295-303, 1992
20. Nenadov-Beck M: LNESG 2 study: Guidelines for the treatment of patients with localized resectable neuroblastoma and analysis of prognostic factors. Presented at E-SIOP Neuroblastoma Meeting, October 21-23, 2004, Cracow, Poland